Theragenics specializes in advanced medical technologies focused on brachytherapy, interventional, and surgical products aimed at improving cancer treatment outcomes. The company is a leading global manufacturer of brachytherapy seeds, including its notable products like TheraSeed® and AgX100®, which are designed for localized cancers such as prostate cancer. These seeds utilize radioisotopes like Cesium-131, which is characterized by its high energy and short half-life, allowing for effective treatment with minimal side effects. Theragenics emphasizes local sourcing and manufacturing to ensure quality and scalability in its product offerings, which also include a range of delivery systems and accessories tailored to meet the diverse needs of healthcare providers.

In addition to brachytherapy, Theragenics is involved in vascular interventions, providing medical devices that enhance procedural outcomes through optimal access. The company also offers bespoke medical device design and manufacturing services, showcasing its commitment to innovation in the medical field. With over 40 years of experience, Theragenics collaborates with healthcare professionals and associations to deliver life-changing treatments, reinforcing its mission to improve patient care and clinical results across various therapeutic areas.

Costa Rica

Theragenics delivers innovative life-changing medical solutions to help you shape better futures for your patients.

We partner with physicians, healthcare providers, medical associations, and manufacturers across the globe to design, produce, and supply minimally invasive medical devices. Our products have resulted in superior procedural and clinical outcomes.

Theragenics was founded in 1981 to develop radiological devices to treat cancer. Since then, we have expanded our offering to include a broad portfolio of design, manufacturing, and finished product solutions across a range of therapeutic areas.

Theragenics

Company Details